Apparatus and method for treating headaches

Patent metadata

Field	Value
Publication number	US-11235146-B2
Application number	US-201515533170-A
Country	US
Kind code	B2
Filing date	Dec 10, 2015
Priority date	Dec 10, 2014
Publication date	Feb 1, 2022
Grant date	Feb 1, 2022

Abstract

The present disclosure generally relates to a system for treating headaches and other pain associated with the occipital nerves. More particularly, the disclosure relates to a system of treating pain by selectively activating specific nerve fibers with a single, fault-resistant contact situated proximate to, but not in direct contact with, portions of one or more the occipital nerves. Additional measures ensure the lead does not migrate or fracture, resulting in long-lasting pain relief.

First claim

The invention claimed is:

1. A method for treating pain in a patient, the method comprising:
verifying the pain is associated with regions innervated by at least one of the patient's occipital nerves so as to identify a targeted region of at least one occipital nerve;
positioning a flexible, coiled neurostimulation lead having a single electrode proximate to, but not in direct physical contact with, the targeted region;
delivering preliminary therapy for a period of time via the lead while simultaneously preventing migration of the lead, the preliminary therapy comprising pulsed electrical signals sufficient to activate the occipital nerve to provide pain relief while avoiding activation of non-target type III and IV nerve fibers within the occipital nerve due to the single electrode being proximate to but not in physical contact with the targeted region; and
removing the lead after the patient reports a reduction in pain.

2. The method of claim 1 , further comprising:
monitoring the pain reported by the patient subsequent to the preliminary therapy;
upon a report from the patient of pain that is similar to the preliminary therapy, providing a surgically implanted system comprising a second flexible, coiled neurostimulation lead positioned proximate to, but not in direct contact with, the targeted region and a subcutaneous electrical stimulation device located proximate to one of the patient's upper chest, clavicle, skull and neck;
connecting the second lead to the electrical stimulation device and subcutaneously fixing the electrical stimulation device within the patient; and
delivering long term therapy via the second lead and the electrical stimulation device.

3. The method according to claim 2 , wherein the electrical stimulation device is attached to the patient's fascia.

4. The method according to claim 1 , wherein the preventing migration of the lead comprises allowing tissue ingrowth within the lead.

5. A method for treating pain in a patient, the method comprising:
verifying the pain is associated with regions innervated by at least one of the patient's occipital nerves so as to identify a targeted region of at least one occipital nerve;
positioning a flexible, coiled neurostimulation lead having a single electrode proximate to, but not in direct physical contact with, the targeted region;
surgically implanting a subcutaneous electrical stimulation device proximate to one of the patient's upper chest, clavicle, skull and neck;
connecting the lead to the electrical stimulation device in parallel;
subcutaneously fixing the electrical stimulation device within the patient; and
delivering neurostimulation therapy via the electrode while simultaneously preventing migration of the lead, the therapy comprising pulsed electrical signals sufficient to activate the occipital nerve to provide pain relief while avoiding activation of non-target type III and IV nerve fibers within the occipital nerve due to the single electrode being proximate to but not in physical contact with the targeted region.

6. The method according to claim 5 , wherein the electrical stimulation device is attached to the patient's fascia.

7. A method for treating pain in a patient, the method comprising:
verifying the pain is associated with regions innervated by at least one of the patient's occipital nerves so as to identify a targeted region of at least one occipital nerve;
positioning a flexible, coiled neurostimulation lead having a single electrode proximate to and spaced a distance from, but not in direct physical contact with, the targeted region; and
delivering therapy for a period of time via the lead while simultaneously preventing migration of the lead, the therapy comprising pulsed electrical signals sufficient to activate the occipital nerve to provide pain relief without stimulating muscle contractions and sensations of discomfort, wherein the pulsed signals are directionally transmitted only to the targeted region while simultaneously preventing the pulsed signals from stimulating non-targeted type III and IV nerve fibers due to the single electrode being spaced the distance from the targeted region.

8. The method according to claim 7 , further comprising providing a plurality of leads and positioning each lead so that each lead is operatively associated with a plurality of targeted regions, said plurality of targeted regions in each located in separate occipital nerves.

9. The method according to claim 7 , wherein the targeted region comprises first and second areas; wherein the electrode includes a length of exposed conductive wires, said length having a first exposed end and a second opposed end with a middle length situated therebetween; and further comprising positioning the first exposed end proximate to and spaced a first exposed distance from, but not in direct physical contact with, the first area and the second exposed end proximate to and spaced a second exposed distance from, but not in direct physical contact with, the second area.

10. The method according to claim 9 , wherein the pulsed signals are adjusted so that appropriate levels of therapeutic current are delivered at the first and second exposed ends while current delivered by the middle length does not stimulate muscle contractions and sensations of discomfort.

11. The method according to claim 9 , wherein the first area is located on a first occipital nerve and the second area is located on a second occipital nerve.

12. The method according to claim 11 , wherein the lead is substantially parallel to a transverse plane.

13. The method according to claim 11 , wherein the lead is substantially parallel to at least one of a sagittal plane and a coronal plane.

14. The method according to claim 7 , wherein the conductive members are arranged to create a plurality of coils in the lead.

15. The method according to claim 7 , wherein the preventing migration of the lead comprises allowing tissue ingrowth within the lead.

Assignees

• Spr Therapeutics Llc
• Spr Therapeutics Inc

Inventors

• Boggs Ii Joseph W
• Wongsarnpigoon Amorn

Classifications

• A61N1/36132

  using patient feedback · CPC title

• A61N1/36075

  Headache or migraine · CPC title

• A61N1/36057

  adapted for stimulating afferent nerves · CPC title

• A61N1/0551 Primary

  Spinal or peripheral nerve electrodes · CPC title

• A61N1/36017

  with leads or electrodes penetrating the skin · CPC title